It hasn't been a great end to the week for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). In afternoon trade the benchmark index is down 0.7% to 5,459 points with declines being seen across every sector.
There have been four shares in particular which have stood out with sharp declines today. Here's why:
Bellamy's Australia Ltd (ASX: BAL) shares have fallen a stunning 38% to $7.50 following the release of a business update which revealed a "temporary volume dislocation due to regulatory changeover". According to the release the Chinese market has been flooded with increasing supply as competitors look to offload their products which are unlikely to satisfy proposed tougher regulatory requirements. Elsewhere, a2 Milk Company Ltd (Australia) (ASX: A2M) shares are also lower despite its recent positive trading update.
BWX Ltd (ASX: BWX) shares are down 6% to $3.96 despite no news out of the company. It appears as though investors are concerned that this skincare company's exports to China may also be impacted by the regulatory changes in China. I believe that this sell off makes BWX a buy. The company's Sukin product has just launched in the UK, which could offset any potential decline in sales in China.
Catapult Group International Ltd (ASX: CAT) shares have plunged 8% to $2.94 a day after the sports analytics company released its FY 2017 revenue guidance. This year Catapult expects revenue to come in between $61 million and $65.5 million, representing pro-forma annual growth of 21% to 30%. Pleasingly the company also expects to deliver positive underlying EBITDA. Catapult is yet another company that I feel looks good value following a sell off today.
ResMed Inc. (CHESS) (ASX: RMD) shares are down over 3% to $8.04 after it emerged that the District Court in Munich had overturned both preliminary injunctions previously granted to the company against rival Fisher & Paykel Healthcare Corp Ltd (ASX: FPH). In August Fisher & Paykel was forced to stop selling the F&P Simplus, Eson and Eson 2 masks in Germany, but sales can recommence following the court's decision. Fisher & Paykel's shares have rallied on the news.
